arrow_back Back to App

Emergency Support for Substance Use Disorders During COVID-19

This act aims to support individuals struggling with substance use disorders during the COVID-19 pandemic. It authorizes grants for organizations providing overdose prevention and harm reduction services, directly improving public health and safety. These funds will help maintain and expand crucial services for those in need.
Key points
Grants will be available to states, tribes, and community-based organizations for drug misuse harm reduction programs.
Funds can be used for distributing life-saving medications (e.g., naloxone), overdose education, and support for individuals with substance use disorders.
Priority for grants will be given to organizations serving areas most affected by COVID-19, with high rates of substance dependence and overdose deaths.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_706
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
Process start date: 2021-02-02
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Emergency Support for Substance Use Disorders Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_706.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-02-02.

What are the main provisions?

Key points include:

  • Grants will be available to states, tribes, and community-based organizations for drug misuse harm reduction programs.
  • Funds can be used for distributing life-saving medications (e.g., naloxone), overdose education, and support for individuals with substance use disorders.
  • Priority for grants will be given to organizations serving areas most affected by COVID-19, with high rates of substance dependence and overdose deaths.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Kuster, Ann M. [D-NH-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health